Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT).
第一作者:
Xianhui,Qin
第一单位:
National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
作者:
主题词
老年人(Aged);中国(China);营养保健品(Dietary Supplements);双盲法(Double-Blind Method);复方合剂(Drug Combinations);依那普利(Enalapril);女(雌)性(Female);叶酸(Folic Acid);高半胱氨酸(Homocysteine);人类(Humans);高血压(Hypertension);高尿酸血症(Hyperuricemia);男(雄)性(Male);中年人(Middle Aged);比值比(Odds Ratio);卒中(Stroke);尿酸(Uric Acid);复合维生素B(Vitamin B Complex)
DOI
10.3945/ajcn.116.143131
PMID
28148501
发布时间
2023-02-14
- 浏览28
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文